Woodgyer A J, Bennetts G P, Rush-Munro F M
New Zealand Communicable Disease Centre, Porirua.
Australas J Dermatol. 1992;33(3):169-76. doi: 10.1111/j.1440-0960.1992.tb00113.x.
The majority of cases of chromoblastomycosis are reported from tropical to subtropical countries; only one previous case being reported from New Zealand. Four non-endemic cases in Pacific Island patients are described. All of the New Zealand cases were caused by Fonsecaea pedrosoi. In the present report, one patient was successfully treated by excision of the lesion followed by skin grafting. Another was treated with 200 mg ketoconazole daily for 10 weeks with no obvious improvement. No follow-up on the treatment of this case nor of the remaining two patients is available. This disease must be included in the differential diagnosis in patients who present with chronic lesions affecting the skin and subcutaneous tissues.
大多数着色芽生菌病病例报告来自热带至亚热带国家；此前新西兰仅报告过1例。本文描述了4例太平洋岛屿患者的非地方性病例。新西兰所有病例均由裴氏着色霉引起。在本报告中，1例患者通过切除病灶并植皮成功治愈。另1例患者每日服用200毫克酮康唑，持续10周，未见明显改善。该病例以及其余2例患者均未进行后续治疗。对于出现影响皮肤和皮下组织的慢性病灶的患者，必须将本病纳入鉴别诊断。
